✦ LIBER ✦

Antigenic cross reactivity between benign prostatic hyperplasia and adenocarcinoma of prostate

✍ Scribed by Frederick Avis; Ingalill Avis; Andrew T. Cole; Floyd Fried; Geoffrey Haughton

Book ID: 119042767
Publisher: Elsevier Science
Year: 1975
Tongue: English
Weight: 189 KB
Volume: 5
Category: Article
ISSN: 0090-4295
DOI: 10.1016/0090-4295(75)90322-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human Papillomavirus in Benign Prostatic

Human Papillomavirus in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma Patients

✍ Alice C.-H. Chen; Tim Waterboer; Annie Keleher; Beth Morrison; Shalini Jindal; D 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 100 KB

Prostatic specific antigen in prostatic

Prostatic specific antigen in prostatic cancer and benign hyperplasia

✍ N. E. Kushlinskii; N. V. Lyubimova; L. M. Gorilovskii 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 411 KB

Prostate-specific antigen and prostate-s

Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression

✍ Jonathan M. Levitt; Kevin M. Slawin 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 148 KB

Prostate-specific antigen and prostate-s

Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression

✍ Jonathan M. Levitt; Kevin M. Slawin 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 154 KB

Tissue concentrations of prostate-specif

Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia

✍ Thomas G. Pretlow; Theresa P. Pretlow; Bin Yang; Charlotte S. Kaetzel; Carrie M. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 775 KB

## Abstract Prostate‐specific antigen (PSA), as measured in peripheral blood, is currently the most widely used marker for the assessment of tumor burden in the longitudinal study of patients with carcinoma of the prostate (PCA). Studies from other laboratories have led to the conclusion that a giv

Increased discrimination between benign

Increased discrimination between benign prostatic hyperplasia and prostate cancer with equimolar total prostate specific antigen measurement

✍ R. Onur; N. Ilhan; I. Orhan; N. Ilhan 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 195 KB